Navigation Links
IDM Pharma Announces Presentations at 44th American Society of Clinical Oncology Annual Meeting
Date:5/16/2008

esponse. IDM Pharma is dedicated to maximizing the full therapeutic and commercial potential of each of its innovative products to address the needs of patients and the physicians who treat these patients.

For more information about the company and its products, visit http://www.idm-pharma.com.

Forward-Looking Statements

The presentations described in this press release will include forward- looking statements that reflect management's current views of future events regarding the development and characteristics of the Company's drug candidates L-MTP-PE and IDM-2101, including the Company's plans to address the remaining questions with respect to the Marketing Authorization Application (MAA) for L- MTP-PE during the clock-stop granted by the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency, and the expected timing of a final opinion from the CHMP and of a final regulatory decision regarding the MAA in the European Union, as well as the Company's plans to collect, analyze and submit additional Phase 3 data in an amended New Drug Application (NDA) for L-MTP-PE, including the expected timing for such amended NDA, and to respond to other matters raised by the Food and Drug Administration (FDA), the potential for IDM-2101 as a treatment for NSCLC and plans to evaluate strategic alternatives. Actual results may differ materially from the forward- looking statements due to a number of important factors, including, but not limited to, whether the Company will be able to respond to the remaining issues with regard to the MAA, including verification of data quality and chemistry, manufacturing and controls (CMC) items, to the satisfaction of the CHMP, whether the CHMP will ask the Company for further information at or following the June 2008 meeting to address remaining issues with regard to the MAA, which would delay the timing of a final opinion from the CHMP, whe
'/>"/>

SOURCE IDM Pharma, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Jazz Pharmaceuticals to Present at Investor Conferences
2. Genesis Pharmaceuticals Reports Results for the Third Quarter of Fiscal Year 2008
3. Carlos A. Parra Joins Alexza Pharmaceuticals as Vice President, Quality
4. Pharmasset Reports Financial Results for Quarter Ended March 31, 2008
5. Wyeths Pristiq, a New Treatment for Major Depressive Disorder in Adults, Now Available in U.S. Pharmacies
6. Tianyin Pharmaceutical Co., Inc. Announces Third Quarter 2008 Financial Results
7. 11 Pharmaceutical Titans Headline Chemistry Outsourcing Conference Program in September in New Jersey
8. AMDL Subsidiary Donates Pharmaceuticals in China Earthquake Relief Effort
9. Alseres Pharmaceuticals, Inc. Reports First Quarter 2008 Operational and Financial Results
10. Pharmacyclics Files Schedule 14D-9 Statement with Securities and Exchange Commission
11. Medsn to Become Indegene Pharmaceutical Solutions, Inc.: Change Signifies the Success of Its Innovative Global Services Model
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... York, NY (PRWEB) June 18, 2013 ... Magnum hip continue to move forward in a multidistrict ... Bernstein Liebhard LLP reports. According to court records, ... June 17th, at which time the Court also convened ... and technical issues pertinent to the Biomet hip replacement ...
(Date:6/18/2013)... a much different and more complex metabolism ... Texas at Dallas have found that exploiting these differences ... , In an article published online May 21 in ... compared the metabolic characteristics of non-small-cell lung cancer cells ... , They found that the cancer cells consumed ...
(Date:6/18/2013)... (PRWEB) June 18, 2013 More than 1.1 ... living with HIV/AIDS, according to the Centers for Disease Control ... they are infected. In support of National HIV Testing Day ... Security Disability Insurance (SSDI) representation, the CDC and other ... , The CDC reports about 50,000 new HIV infections ...
(Date:6/18/2013)... Two months ago, Suyima Torres, 28, died from respiratory ... of a silicone treatment for gluteus augmentation at Cuerpos Health ... by a mystery Venezuelan doctor in a center that was ... Vazquez of Bayshore Cosmetic Surgery , women suffering from ... not board certified is more common than people think. ...
(Date:6/18/2013)... New York, New York (PRWEB) June 18, 2013 ... forward in both state and federal court, a new report ... of more than 70,000 U.S. Food & Drug Administration (FDA) ... According to NewsChannel5 in Cleveland, Ohio, over 4.700 Mirena ... since 2008, while more than 1,300 have reportedly experienced uterine ...
Breaking Medicine News(10 mins):Health News:Biomet Hip Lawsuit News: Bernstein Liebhard LLP Reports on Latest Status Conference in Federal Biomet Hip Replacement Litigation 2Health News:Biomet Hip Lawsuit News: Bernstein Liebhard LLP Reports on Latest Status Conference in Federal Biomet Hip Replacement Litigation 3Health News:UT Dallas study suggests new approach to fight lung cancer 2Health News:UT Dallas study suggests new approach to fight lung cancer 3Health News:Allsup Observes National HIV Testing Day June 27 2Health News:Allsup Observes National HIV Testing Day June 27 3Health News:Dr. Bernabe Vazquez Speaks on Miami Woman’s Deadly Silicone Butt Injection 2Health News:Dr. Bernabe Vazquez Speaks on Miami Woman’s Deadly Silicone Butt Injection 3Health News:Mirena Lawsuit News: Bernstein Liebhard LLP Comments on Mounting Reports of Mirena Side Effects, Including Device Migration, Uterine Perforations 2Health News:Mirena Lawsuit News: Bernstein Liebhard LLP Comments on Mounting Reports of Mirena Side Effects, Including Device Migration, Uterine Perforations 3
... researchers find , , WEDNESDAY, Jan. 9 (HealthDay News) -- Drinking ... keeping heart disease at bay, Danish researchers report. , In ... a 30 percent to 49 percent higher risk of developing ... , "This study is consistent with a number of ...
... Pa., Jan. 8 ViroPharma Incorporated,(Nasdaq: VPHM ... petition to the,U.S. Food and Drug Administration (FDA) ... the company,s continuing efforts to assure the safety ... its views on the in vitro dissolution bioequivalence,method ...
... Texas, Jan. 8 In 2006, 66% of Americans ... come from working in,seated sedentary jobs? Or do we ... or obese? No one knows for sure, but Texas ... to reverse this trend. Recently,Neutral Posture introduced the Ntune(TM) ...
... Quality Assurance Certifies Quality of Health ... ... Community Care of,Georgia announced today that it has been awarded New ... it offers high-quality services to its 218,000 members., NCQA is ...
... Academic Alliance,Foundation announces the publishing of Global HIV/AIDS ... approach to the management of,HIV/AIDS as a global ... prevention, diagnosis, and treatment, with particular emphasis on,the ... "On behalf of each of the editors, we ...
... by the American Association for Homecare, ARLINGTON, Va., ... supports efforts to crack down on,Medicare fraud announced today ... the Centers for Medicare and Medicaid Services (CMS) on ... agencies and,Congress to prevent fraudulent activity in the durable ...
Cached Medicine News:Health News:Drink a Little, Stay Active, Save Your Heart 2Health News:Drink a Little, Stay Active, Save Your Heart 3Health News:ViroPharma Provides Update on Vancocin(R) 2Health News:ViroPharma Provides Update on Vancocin(R) 3Health News:ViroPharma Provides Update on Vancocin(R) 4Health News:Office Furniture That Helps Fight Fat! 2Health News:AMERIGROUP Community Care of Georgia Wins New Health Plan Accreditation from NCQA 2Health News:Academic Alliance Foundation Announces Publishing of Global HIV/AIDS Medicine 2Health News:Academic Alliance Foundation Announces Publishing of Global HIV/AIDS Medicine 3Health News:Medicare Anti-Fraud Measures are Way Overdue, Says Durable Medical Equipment Industry 2Health News:Medicare Anti-Fraud Measures are Way Overdue, Says Durable Medical Equipment Industry 3
(Date:6/18/2013)... , June 18, 2013 Royal ... company was named Overall Performance Leader in Imaging Equipment ... & Infrastructure report. Philips also received Best in KLAS ... imaging products: Ingenuity Core 128 Computed Tomography (CT), ... and PageWriter TC70 cardiograph. The annual Best in KLAS ...
(Date:6/18/2013)... 2013  Cataracts are the leading cause of blindness ... Ophthalmology, aging is the leading cause of eye diseases ... lens. 22 million Americans age 40 and older have ... age, that number will increase over 30 million.  In ... smart-phones and computers, the demographic of ages 40 plus ...
(Date:6/18/2013)... NEW YORK , June 18, 2013 MPR ... design with its June 2013 edition. It,s all part of ... the publication, trusted by healthcare practitioners for over 28 years. ... Through a continuous evolution MPR has ... for prescribers and has grown to include an increasing array ...
Breaking Medicine Technology:Philips Named 2013 Overall Performance Leader In Imaging Equipment By KLAS 2New Vision Hope For Millions Undergoing Cataract Surgery 2New Vision Hope For Millions Undergoing Cataract Surgery 3MPR Sports a Bold New Look 2
... FORD, Pa., Oct. 12, 2011 Endo Pharmaceuticals (Nasdaq: ... results on October 27, 2011 and will host a conference ... discuss these results.   David P. Holveck, president ... Ivan Gergel, executive vice president of R&D, Alan Levin, executive ...
... Aircraft Medical ("Aircraft"), the UK medical devices company, today ... Covidien (NYSE: COV ), a leading global ... billion, and 41,000 employees worldwide. Under the ... Aircraft,s proprietary McGRATH ® MAC video laryngoscope in ...
Cached Medicine Technology:Endo Pharmaceuticals to Announce Third Quarter 2011 Financial Results on October 27, 2011 2Aircraft Medical Signs Multinational Distribution Agreement with Covidien for McGRATH® MAC Video Laryngoscope 2
The Professional ophthalmoscope has been designed to ensure ultimate control. Lenses, graticules and filters can all be introduced at the touch of a fingertip without the need to pull away from the p...
... The Iris Diagnostics iQ200 Automated ... imaging and Auto-Particle Recognition (APR) software ... categories and quantitatively report results. The ... to prepare and interpret particle images ...
A flexible hematology platform:, 32 parameters, Automatic result validation, Cytology atlas included, CBC and 5+3 DIFF...
... 3.5x, 4.5x and 5.5x magnification., ,Higher ... quality guarantees a true image. Edge ... rendition is ideal for intricate surgical ... treated with an anti-reflective coating to ...
Medicine Products: